Cat. No S57C4X-1374_5_MG
US-CATO

Product Information

Product Name
Idarubicin Hydrochloride
Brand Name
US-CATO
Product Number
C4X-1374
CAS
57852-57-0
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
636362
IUPAC Name
(7S,9S)-9-acetyl-7-(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yloxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
InChI Key
JVHPTYWUBOQMBP-RVFAQHLVSA-N
SMILES
CC@H1C@H(C@H(CC@@H(O1)OC@H2CC@@(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O.Cl

References Data Source From Pubchem

The Impact of Conventional Chemotherapy Regimens and Targeted Drugs on Ovarian Function in Breast Cancer Patients

Publication Name: Reproductive sciences (Thousand Oaks, Calif.)
Publication Date: 2026-03-02
DOI: 10.1007/s43032-026-02067-x

Post-marketing surveillance of quizartinib for relapsed or refractory FLT3-ITD-positive acute myeloid leukemia in Japan

Publication Name: International Journal of Hematology
Publication Date: 2026-02-26
DOI: 10.1007/s12185-026-04181-7

Treatment Outcomes and Factors Affecting Survival in Pediatric Acute Myeloid Leukemia

Publication Name: Annals of Hematology
Publication Date: 2026-02-26
DOI: 10.1007/s00277-026-06906-4

Beyond Remission: The Cardiotoxic and Thrombotic Shadow of AML Chemotherapy

Publication Name: Cardiovascular Toxicology
Publication Date: 2026-02-24
DOI: 10.1007/s12012-026-10104-z

The FGFR1 N546K mutation confers resistance to pemigatinib in MLN-ZMYM2::FGFR1

Publication Name: Leukemia
Publication Date: 2026-02-20
DOI: 10.1038/s41375-026-02890-w

Idarubicin Hydrochloride

Just added to your wishlist:
My Wishlist
You've just added this product to the cart:
Go to cart page